Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Predictors of Hospitals' Nonachievement of Baseline Nursing Standards for Pediatric Oncology.

Sullivan CE, Morrissey L, Day SW, Chen Y, Shirey M, Landier W.

Cancer Nurs. 2019 Mar 29. doi: 10.1097/NCC.0000000000000688. [Epub ahead of print]

PMID:
30932923
2.

Disparities in the delivery of pediatric oncology nursing care by country income classification: International survey results.

Morrissey L, Lurvey M, Sullivan C, Challinor J, Forbes PW, Abramovitz L, Afungchwi GM, Hollis R, Day S.

Pediatr Blood Cancer. 2019 Jun;66(6):e27663. doi: 10.1002/pbc.27663. Epub 2019 Feb 20.

PMID:
30786168
3.

Uncovering vector, parasite, blood meal and microbiome patterns from mixed-DNA specimens of the Chagas disease vector Triatoma dimidiata.

Orantes LC, Monroy C, Dorn PL, Stevens L, Rizzo DM, Morrissey L, Hanley JP, Rodas AG, Richards B, Wallin KF, Helms Cahan S.

PLoS Negl Trop Dis. 2018 Oct 18;12(10):e0006730. doi: 10.1371/journal.pntd.0006730. eCollection 2018 Oct.

4.

Impact of Nivolumab versus Docetaxel on Health-Related Quality of Life and Symptoms in Patients with Advanced Squamous Non-Small Cell Lung Cancer: Results from the CheckMate 017 Study.

Reck M, Taylor F, Penrod JR, DeRosa M, Morrissey L, Dastani H, Orsini L, Gralla RJ.

J Thorac Oncol. 2018 Feb;13(2):194-204. doi: 10.1016/j.jtho.2017.10.029. Epub 2017 Nov 10.

5.

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.

Harrington KJ, Ferris RL, Blumenschein G Jr, Colevas AD, Fayette J, Licitra L, Kasper S, Even C, Vokes EE, Worden F, Saba NF, Kiyota N, Haddad R, Tahara M, Grünwald V, Shaw JW, Monga M, Lynch M, Taylor F, DeRosa M, Morrissey L, Cocks K, Gillison ML, Guigay J.

Lancet Oncol. 2017 Aug;18(8):1104-1115. doi: 10.1016/S1470-2045(17)30421-7. Epub 2017 Jun 23.

6.

A Prospective Cohort Quality Improvement Study to Reduce the Time to Antibiotics for New Fever in Neutropenic Pediatric Oncology Inpatients.

Green AL, Yi J, Bezler N, Pikman Y, Tubman VN, Obeng EA, O'Neil T, Mersereau R, Morrissey L, Billett AL.

Pediatr Blood Cancer. 2016 Jan;63(1):112-7. doi: 10.1002/pbc.25712. Epub 2015 Aug 20.

PMID:
26292080
7.

Geospatial and Temporal Analysis of Thyroid Cancer Incidence in a Rural Population.

Hanley JP, Jackson E, Morrissey LA, Rizzo DM, Sprague BL, Sarkar IN, Carr FE.

Thyroid. 2015 Jul;25(7):812-22. doi: 10.1089/thy.2015.0039. Epub 2015 Jun 2. Erratum in: Thyroid. 2015 Dec;25(12):1385.

8.

A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.

Suarez A, Piña M, Nichols-Vinueza DX, Lopera J, Rengifo L, Mesa M, Cardenas M, Morrissey L, Veintemilla G, Vizcaino M, Del Toro L, Vicuna V, Fernandez J, Neuberg D, Stevenson K, Gutierrez A.

Pediatr Blood Cancer. 2015 Aug;62(8):1395-402. doi: 10.1002/pbc.25510. Epub 2015 Mar 24.

PMID:
25808195
9.

Sources of blood meals of sylvatic Triatoma guasayana near Zurima, Bolivia, assayed with qPCR and 12S cloning.

Lucero DE, Ribera W, Pizarro JC, Plaza C, Gordon LW, Peña R Jr, Morrissey LA, Rizzo DM, Stevens L.

PLoS Negl Trop Dis. 2014 Dec 4;8(12):e3365. doi: 10.1371/journal.pntd.0003365. eCollection 2014 Dec.

10.

Words of wisdom: OR leaders offer tips for new managers.

Byrd J, Miller KF, Morrissey L, Murphy M, Peratino BA, Shaneberger K.

OR Manager. 2013 Aug;29(8):1, 6-9. No abstract available.

PMID:
24003623
11.

Development of a complex orientation program for multidisciplinary training.

Hemingway M, Morrissey L.

AORN J. 2013 Jun;97(6):718-27. doi: 10.1016/j.aorn.2013.04.011.

PMID:
23722036
12.

Hereditary metabolic diseases (HMDs) in adult practice in Ireland: a preliminary assessment.

Morrissey L, Tiernan CA, Lambert D, O'Reilly E, Treacy EP.

Ir J Med Sci. 2013 Dec;182(4):565-71. doi: 10.1007/s11845-013-0927-9. Epub 2013 Mar 23.

PMID:
23526233
13.

Ecohealth interventions limit triatomine reinfestation following insecticide spraying in La Brea, Guatemala.

Lucero DE, Morrissey LA, Rizzo DM, Rodas A, Garnica R, Stevens L, Bustamante DM, Monroy MC.

Am J Trop Med Hyg. 2013 Apr;88(4):630-7. doi: 10.4269/ajtmh.12-0448. Epub 2013 Feb 4.

14.

Global challenges in pediatric oncology.

Rodriguez-Galindo C, Friedrich P, Morrissey L, Frazier L.

Curr Opin Pediatr. 2013 Feb;25(1):3-15. doi: 10.1097/MOP.0b013e32835c1cbe. Review.

PMID:
23295716
15.

FGFR1 amplification in squamous cell carcinoma of the lung.

Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ.

J Thorac Oncol. 2012 Dec;7(12):1775-1780. doi: 10.1097/JTO.0b013e31826aed28.

16.

Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.

Volpe D, Harrison S, Damian F, Rachh P, Kahlon PS, Morrissey L, Mack J, Akenroye A, Stack AM.

Pediatrics. 2012 Jul;130(1):e201-10. doi: 10.1542/peds.2012-0153. Epub 2012 Jun 18.

PMID:
22711718
17.

Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.

Sequist LV, Heist RS, Shaw AT, Fidias P, Rosovsky R, Temel JS, Lennes IT, Digumarthy S, Waltman BA, Bast E, Tammireddy S, Morrissey L, Muzikansky A, Goldberg SB, Gainor J, Channick CL, Wain JC, Gaissert H, Donahue DM, Muniappan A, Wright C, Willers H, Mathisen DJ, Choi NC, Baselga J, Lynch TJ, Ellisen LW, Mino-Kenudson M, Lanuti M, Borger DR, Iafrate AJ, Engelman JA, Dias-Santagata D.

Ann Oncol. 2011 Dec;22(12):2616-24. doi: 10.1093/annonc/mdr489. Epub 2011 Nov 9.

18.

BioWeld(®) Tube and surgical glue for experimental sutureless venous microanastomosis.

Schwaiger N, Wu J, Wright B, Morrissey L, Harris M, Rohanizadeh R.

Br J Surg. 2010 Dec;97(12):1825-30. doi: 10.1002/bjs.7257. Epub 2010 Oct 1.

PMID:
20890932
19.

Adaptive leadership and the practice of medicine: a complexity-based approach to reframing the doctor-patient relationship.

Thygeson M, Morrissey L, Ulstad V.

J Eval Clin Pract. 2010 Oct;16(5):1009-15. doi: 10.1111/j.1365-2753.2010.01533.x.

PMID:
20846289
20.

Expanding the role of nonclinical personnel in the OR.

Hemingway M, Freehan M, Morrissey L.

AORN J. 2010 Jun;91(6):753-61. doi: 10.1016/j.aorn.2009.11.067.

PMID:
20510948
21.

Informed choice assistance for women making uterine fibroid treatment decisions: a practical clinical trial.

Solberg LI, Asche SE, Sepucha K, Thygeson NM, Madden JE, Morrissey L, Kraemer KK, Anderson LH.

Med Decis Making. 2010 Jul-Aug;30(4):444-52. doi: 10.1177/0272989X09353947. Epub 2009 Nov 30.

PMID:
19949063
22.

Evaluating preference-sensitive care for uterine fibroids: it's not so simple.

Solberg LI, Asche SE, Anderson LH, Sepucha K, Thygeson NM, Madden JE, Morrissey L, Kraemer KK.

J Womens Health (Larchmt). 2009 Jul;18(7):1071-9. doi: 10.1089/jwh.2008.0948.

PMID:
19580366
23.

Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain.

Morrissey LK, Shea JO, Kalish LA, Weiner DL, Branowicki P, Heeney MM.

Pediatr Blood Cancer. 2009 Mar;52(3):369-72. doi: 10.1002/pbc.21847.

PMID:
19023890
24.

Laser-assisted end-to-end BioWeld anastomosis in an ovine model.

Wright B, Vicaretti M, Schwaiger N, Wu J, Trickett R, Morrissey L, Rohanizadeh R, Fletcher J, Maitz P, Harris M.

Lasers Surg Med. 2007 Sep;39(8):667-73.

PMID:
17886280
25.

Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.

Greco FA, Thompson DS, Morrissey LH, Erland JB, Burris HA 3rd, Spigel DR, Joseph G, Corso SW, Spremulli E, Hainsworth JD.

Oncologist. 2005 Oct;10(9):728-33.

26.

Rituximab plus short-duration chemotherapy as first-line treatment for follicular non-Hodgkin's lymphoma: a phase II trial of the minnie pearl cancer research network.

Hainsworth JD, Litchy S, Morrissey LH, Andrews MB, Grimaldi M, McCarty M, Greco FA.

J Clin Oncol. 2005 Mar 1;23(7):1500-6. Epub 2005 Jan 4.

PMID:
15632411
27.

Carcinoma of unknown primary site: sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: a Minnie Pearl Cancer Research Network phase II trial.

Greco FA, Rodriguez GI, Shaffer DW, Hermann R, Litchy S, Yardley DA, Burris HA 3rd, Morrissey LH, Erland JB, Hainsworth JD.

Oncologist. 2004;9(6):644-52.

28.

Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.

Meluch AA, Greco FA, Morrissey LH, Raefsky EL, Steis RG, Butts JA, Hainsworth JD; Minnie Pearl Cancer Research Network.

Cancer. 2003 Nov 15;98(10):2192-8.

29.

Rituximab as first-line and maintenance therapy for patients with indolent non-hodgkin's lymphoma.

Hainsworth JD, Litchy S, Burris HA 3rd, Scullin DC Jr, Corso SW, Yardley DA, Morrissey L, Greco FA.

J Clin Oncol. 2002 Oct 15;20(20):4261-7.

PMID:
12377971
30.
31.

Paclitaxel, carboplatin, and topotecan in the treatment of patients with small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Morrissey LH, Scullin DC Jr, Houston GA, Prasthofer EF, Gray JR, Burris HA 3rd, Greco FA.

Cancer. 2002 May 1;94(9):2426-33.

32.

Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study.

Greco FA, Burris HA 3rd, Litchy S, Barton JH, Bradof JE, Richards P, Scullin DC Jr, Erland JB, Morrissey LH, Hainsworth JD.

J Clin Oncol. 2002 Mar 15;20(6):1651-6.

PMID:
11896116
33.

Paclitaxel and carboplatin adjuvant therapy alone or with radiotherapy for resected nonsmall cell lung carcinoma: a feasibility study of the Minnie Pearl Cancer Research Network.

Greco FA, Burris HA 3rd, Gray JR, Raefsky EL, Dobbs C, Smith S, Rinaldi D, Morrissey LH, Erland JB, Litchy S, Hainsworth JD.

Cancer. 2001 Oct 15;92(8):2142-7.

PMID:
11596031
34.
35.

Taxane-based chemotherapy for patients with carcinoma of unknown primary site.

Greco FA, Gray J, Burris HA 3rd, Erland JB, Morrissey LH, Hainsworth JD.

Cancer J. 2001 May-Jun;7(3):203-12.

PMID:
11419028
36.

Paclitaxel and gemcitabine chemotherapy for advanced transitional-cell carcinoma of the urothelial tract: a phase II trial of the Minnie pearl cancer research network.

Meluch AA, Greco FA, Burris HA 3rd, O'Rourke T, Ortega G, Steis RG, Morrissey LH, Johnson V, Hainsworth JD.

J Clin Oncol. 2001 Jun 15;19(12):3018-24.

PMID:
11408496
37.

Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II Trial.

Hainsworth JD, Burris HA 3rd, Litchy S, Morrissey LH, Barton JH, Bradof JE, Greco FA.

Cancer. 2000 Jul 15;89(2):328-33.

PMID:
10918162
38.

Paclitaxel, carboplatin, and vinorelbine in the treatment of advanced non-small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Hainsworth JD, Burris HA 3rd, Morrissey LH, Thomas M, Erland JB, Butts JA, Joseph G, Kalman L, Greco FA.

Cancer J. 2000 May-Jun;6(3):151-6.

PMID:
10882330
39.

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.

Hainsworth JD, Burris HA 3rd, Morrissey LH, Litchy S, Scullin DC Jr, Bearden JD 3rd, Richards P, Greco FA.

Blood. 2000 May 15;95(10):3052-6.

40.

Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin.

Greco FA, Erland JB, Morrissey LH, Burris HA 3rd, Hermann RC, Steis R, Thompson D, Gray J, Hainsworth JD.

Ann Oncol. 2000 Feb;11(2):211-5.

PMID:
10761758
41.

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.

Burris HA 3rd, Hainsworth JD, Erland JB, Morrissey LH, Kalman LA, Hon JK, Scullin DC Jr, Smith SW, Greco FA.

Semin Oncol. 2000 Feb;27(1 Suppl 2):9-13.

PMID:
10697030
42.

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.

Hainsworth JD, Burris HA 3rd, Erland JB, Morrissey LH, Meluch AA, Kalman LA, Hon JK, Scullin DC Jr, Smith SW, Greco FA.

Cancer. 1999 Mar 15;85(6):1269-76.

PMID:
10189131
44.

Energy transfer assays of rat renal cortical endosomal fusion: evidence for superfusion.

Hammond TG, Majewski RR, Muse KE, Oberley TD, Morrissey LW, Amendt-Raduege AM.

Am J Physiol. 1994 Dec;267(6 Pt 2):F1021-33.

PMID:
7810689
45.

Tumor cell kinetics using two labels and flow cytometry.

Ritter MA, Fowler JF, Kim YJ, Gilchrist KW, Morrissey LW, Kinsella TJ.

Cytometry. 1994 May 1;16(1):49-58.

46.

The photocatalytic production of organic-free water for molecular biological and pharmaceutical applications.

Cooper G, Borish L, Mascali J, Watson C, Kirkegaard K, Morrissey L, Tedesco JL.

J Biotechnol. 1994 Mar 31;33(2):123-33.

PMID:
7764728
47.

Bivariate flow karyotyping, sorting, and peak assignment of all rat chromosomes.

Shepel LA, Morrissey LW, Hsu LC, Gould MN.

Genomics. 1994 Jan 1;19(1):75-85.

PMID:
8188245
48.

Heart-lung protection from ischemic injury during 8 hour hypothermic preservation.

Le Gal YM, Scott T, Prabhakaran VM, Zhang J, Pushpanathan C, Morrissey L.

Acta Biomed Ateneo Parmense. 1994;65(3-4):181-98. Review.

PMID:
7717031
49.

Forward scatter pulse width signals resolve multiple populations of endosomes.

Hammond TG, Majewski RR, Morré DJ, Schell K, Morrissey LW.

Cytometry. 1993;14(4):411-20.

50.

Detection of borreliacidal antibodies in hamsters by using flow cytometry.

Sachsenmeier KF, Schell K, Morrissey LW, Pennell DR, West RM, Callister SM, Schell RF.

J Clin Microbiol. 1992 Jun;30(6):1457-61.

Supplemental Content

Loading ...
Support Center